Lupin gains on GMP certificate from Japan’s drug regulator


Share price of Lupin added 1.8 percent intraday on October 9 after the pharma company received a good manufacturing practice (GMP certificate) from a Japanese regulator for its Mandideep facility.

The company had received the GMP certificate from Japan’s Pharmaceutical and Medical Devices Agency for its Mandideep API facility (Unit II), Lupin said in a BSE release.

The PMDA inspected the facility between May 14, 2019 and May 17, 2019 and closed the inspection with no critical or major observations.

The GMP certificate will be valid till September 2024.

At 1144 hours, Lupin was quoting at Rs 674.10, up Rs 5.30, or 0.79 percent, on the BSE.

The share touched its 52-week high Rs 914 and 52-week low Rs 646.20 on October 31, 2018 and October 7, 2019, respectively.

It is trading 26.25 percent below its 52-week high and 4.32 percent above its 52-week low.

News Source: MoneyControl

For Enquiry Fill The Form

*Note:- Please provide a valid Email Id to receive OTP from

Facebook Iconfacebook like buttonYouTube IconTwitter Icontwitter follow button